Wedbush maintains Neutral rating on Abivax, $118 price target
Wedbush kept a Neutral rating on Abivax and set a $118.00 price target, implying 30.2% upside versus the Sep 21 close of $90.65.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.